AI-generated summary
The authors retrospectively reviewed 467 inpatients with depressive, bipolar or generalized anxiety disorder treated with a combination of bright light therapy, repetitive transcranial magnetic stimulation and medication. They report that higher baseline white blood cell counts were linked to lower remission rates in bipolar and major depressive disorder, and that bright light therapy effects varied with baseline inflammation. As a retrospective observational study, it cannot establish cause and effect.
- Participants
- 467
- Who or what was studied
- Inpatients with major depressive, bipolar, or generalized anxiety disorder treated at Hangzhou Seventh People's Hospital between April 2022 and April 2024
- Limits stated in the abstract
- The study is retrospective and observational, so associations cannot establish causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Anxiety, Transcranial magnetic stimulation, Bright light therapy, Light-emitting diode, Observational study, Inflammation, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.